Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Pergolizzi

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
Cureus|November 6, 2023
Brave New Healthcare: A Narrative Review of Digital Healthcare in American MedicineJoseph Pergolizzi, Jo Ann K LeQuang, Ingrid Vasiliu-Feltes, et al.
Medical Sciences (Basel, Switzerland)|January 17, 2023
The Effect of COVID-19 on Maternal Mental Health and Medical SupportLaura Catalina Merlano, Sindhu Nagarakanti, Kailyn Mitchell, et al.
Journal of Medical Economics|September 7, 2010
The societal impact of pain in the European Union: health-related quality of life and healthcare resource utilizationPaul Langley, Gerhard Müller-Schwefe, Andrew Nicolaou, et al.
Pain Practice : the Official Journal of World Institute of Pain|June 19, 2016
Efficacy and Safety of Once-Daily Extended-Release (ER) Hydrocodone in Individuals Previously Receiving ER Morphine for Chronic PainKathleen Broglio, Joseph Pergolizzi, Maribeth Kowalski, et al.
Cureus|July 24, 2023
From Antidepressant Tianeptine to Street Drug ZaZa: A Narrative ReviewMorgan L Wagner, Joseph Pergolizzi, Jo Ann K LeQuang, et al.
Geriatric Nursing (New York, N.Y.)|August 10, 2016
Long-term effectiveness and safety of once-daily, single-entity, extended-release hydrocodone in patients of ≥75 years of age with moderate to severe nonmalignant and nonneuropathic painKathleen Broglio, Joseph Pergolizzi, Maribeth Kowalski, et al.
Pain Physician|July 13, 2012
Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphineJonathan Daitch, Michael E Frey, David Silver, et al.
Journal of Medical Economics|November 2, 2010
The impact of pain on labor force participation, absenteeism and presenteeism in the European UnionPaul Langley, Gerhard Müller-Schwefe, Andrew Nicolaou, et al.
Journal of Opioid Management|June 20, 2014
Evaluation of the tamper-resistant properties of tapentadol extended-release tablets: results of in vitro laboratory analysesEric Galia, Yinka Williams, Ben Van Hove, et al.
Cureus|February 6, 2023
Exploring the Implications of New-Onset Diabetes in COVID-19: A Narrative ReviewJoseph Pergolizzi, Jo Ann K LeQuang, Frank Breve, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Cureus|November 6, 2023
Brave New Healthcare: A Narrative Review of Digital Healthcare in American MedicineJoseph Pergolizzi, Jo Ann K LeQuang, Ingrid Vasiliu-Feltes, et al.
Medical Sciences (Basel, Switzerland)|January 17, 2023
The Effect of COVID-19 on Maternal Mental Health and Medical SupportLaura Catalina Merlano, Sindhu Nagarakanti, Kailyn Mitchell, et al.
Journal of Medical Economics|September 7, 2010
The societal impact of pain in the European Union: health-related quality of life and healthcare resource utilizationPaul Langley, Gerhard Müller-Schwefe, Andrew Nicolaou, et al.
Pain Practice : the Official Journal of World Institute of Pain|June 19, 2016
Efficacy and Safety of Once-Daily Extended-Release (ER) Hydrocodone in Individuals Previously Receiving ER Morphine for Chronic PainKathleen Broglio, Joseph Pergolizzi, Maribeth Kowalski, et al.
Cureus|July 24, 2023
From Antidepressant Tianeptine to Street Drug ZaZa: A Narrative ReviewMorgan L Wagner, Joseph Pergolizzi, Jo Ann K LeQuang, et al.
Geriatric Nursing (New York, N.Y.)|August 10, 2016
Long-term effectiveness and safety of once-daily, single-entity, extended-release hydrocodone in patients of ≥75 years of age with moderate to severe nonmalignant and nonneuropathic painKathleen Broglio, Joseph Pergolizzi, Maribeth Kowalski, et al.
Pain Physician|July 13, 2012
Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphineJonathan Daitch, Michael E Frey, David Silver, et al.
Journal of Medical Economics|November 2, 2010
The impact of pain on labor force participation, absenteeism and presenteeism in the European UnionPaul Langley, Gerhard Müller-Schwefe, Andrew Nicolaou, et al.
Journal of Opioid Management|June 20, 2014
Evaluation of the tamper-resistant properties of tapentadol extended-release tablets: results of in vitro laboratory analysesEric Galia, Yinka Williams, Ben Van Hove, et al.
Cureus|February 6, 2023
Exploring the Implications of New-Onset Diabetes in COVID-19: A Narrative ReviewJoseph Pergolizzi, Jo Ann K LeQuang, Frank Breve, et al.
Pageof 9